Table 3.
Dependent variable | Variables taken into account | BME effect |
---|---|---|
MRCP(UK) Part 1 | - | beta = −.265, p < .001, b = −64.70 |
N = 1988 | ||
MRCP(UK) Part2 | MRCP(UK) Part 1 | beta = −.163, p < .001, b = −24.95 |
N = 942 | ||
MRCP(UK) PACES | MRCP(UK) Part 1 & Part2 | beta = −.240, p < .001, b = −10.55 |
N = 741 | ||
MRCGP AKT | MRCP(UK) Part 1, Part 2 & PACES | beta = −.127, p < .001, b = −3.03 |
N = 741 | ||
MRCGP CSA | MRCGP AKT; MRCP(UK) Part 1, Part 2 & PACES | beta = −.208, p < .001, b = −5.11 |
N = 741 | ||
MRCGP AKT - CM | Part1, Part2, PACES | beta = −.105, p = .001, b = −1.23 |
(Clinical Medicine) | N = 741 | |
MRCGP AKT – EI | Part1, Part2, PACES | beta = −.079, p = .024, b = −2.21 |
(Evidence Interpretation) | N = 741 | |
MRCGP AKT – O | Part1, Part2, PACES | beta = −.123, p = .001, b = −3.02 |
(Organisational) | N = 741 | |
MRCGP AKT - CM | MRCP(UK) Part 1, Part 2 & PACES; MRCGP AKT-EI & AKT-O | beta = −.075, p = .01 , b = −0.88 |
(Clinical Medicine) | N = 741 | |
MRCGP AKT – EI | MRCP(UK) Part 1, Part 2 & PACES; MRCGP AKT-CM & AKT-O | beta = −.029, NS (p = .393) , b = −0.78 |
(Evidence Interpretation) | N = 741 | |
MRCGP AKT – O | MRCP(UK) Part 1, Part 2 & PACES; MRCGP AKT-CM & AKT-EI | beta = −.087, p = .015, b = −2.13 |
(Organisational) | N = 741 |
Notes: For the various assessments shown in the first column, the effects are shown in the third column, after taking into account performance on previous assessments, shown in the second column. A negative beta or b coefficient indicates that BME candidates perform less well than White candidates.